Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Andrew J.S. Furness

Andrew Furness

United Kingdom

Royal Marsden NHS Foundation Trust

Andrew completed his medical training at Guy’s, King’s and St Thomas’ School of Medicine, London. Following completion core training in Internal Medicine, he underwent specialist training in Medical Oncology at The Royal Marsden NHS Foundation Trust.

In 2013, he joined the laboratory of Sergio Quezada and Karl Peggs and spent 4 years studying Cancer Immunology at University College London Cancer Institute.  During this time he studied the immunological landscape of human tumours and made fundamental contributions to current understanding of the mechanisms underlying the activity of immune modulatory antibody-based therapies.

His findings have been published in high impact journals including Cancer Cell, Immunity and Science and his efforts have been recognised with a number of awards including the Association of Cancer Physicians McElwain prize and Cancer Research UK Translational Research Prize. 

He is passionate about making tangible improvements for patients and plans to achieve this through a career combining Medicine and Science.

He is a faculty member of the ESMO Tumour Immunology and Immunotherapy group and sits on the scientific committee for this year’s Immuno-Oncology Congress in Geneva.  

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.